Advance Agrolife IPO kick-off for bidding today: Should you subscribe to it?
Advance Agrolife IPO opens from Sep 30 to Oct 3, 2025, with a price band of ₹95-₹100. This ₹192.86 Cr fresh issue aims to fund working capital. Check the latest subscription status, GMP, financial analysis, and brokerage views before you subscribe.
Company Overview:
Advance Agrolife Limited (Incorporated 2002, Jaipur-based) is an agrochemical company engaged in manufacturing and distributing a diverse range of products.
- Product Portfolio: Includes insecticides, herbicides, fungicides, plant growth regulators, micronutrients, and bio-fertilizers. They produce both Technical-Grade (raw active ingredients) and Formulation-Grade (ready-made finished products).
- Market Presence: Operates a B2B model, serving large agrochemical corporations like DCM Shriram and Mankind Agritech in 19 Indian states and 3 union territories. Also exports to countries including the UAE, Bangladesh, Turkey, Egypt, and Nepal.
- Registrations: Holds 410 generic registrations (380 formulation-grade and 30 technical-grade) as of March 2025.
Advance Agrolife IPO Details:
- Issue Size: ₹192.86 crore, entirely a Fresh Issue of up to 1,92,85,720 equity shares.
- Price Band: ₹95 to ₹100 per equity share.
- Face Value: ₹10 per equity share.
- Bidding Dates: September 30, 2025, to October 3, 2025.
- Lot Size: 150 equity shares (Minimum investment of ₹15,000 at the upper price band).
- Listing: Proposed to list on BSE and NSE (Tentative listing date: October 8, 2025).
- Objective: Proceeds (approx. ₹135 crore) will be primarily used for funding working capital requirements and the balance for general corporate purposes.
- Lead Manager & Registrar: Choice Capital Advisors (BRLM) and Kfin Technologies (Registrar).
Financial Highlights (FY25):
- Revenue from Operations: ₹502.88 crore.
- Profit After Tax (PAT): ₹25.64 crore.
- Valuation: Valued at a P/E of approximately 25.1 times FY25 earnings at the upper price band, which is near the industry average.
Analyst Views & Market Sentiment:
- Brokerage Views: Mixed, with some assigning a ‘Subscribe’ rating citing superior return ratios (ROE and ROCE) and competitive P/E compared to the industry average. Others have assigned a ‘Neutral’ view due to sector volatility and the need to monitor performance post-listing.
- Grey Market Premium (GMP): Indicating a modest premium of around 9-15% over the issue price, suggesting a likely listing pop.
